Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2018-11-27 AGM Information
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
关于召开2018年第七次临时股东大会的提示性公告
AGM Information Classification · 95% confidence The document is a detailed announcement about the convening of the 2018 seventh extraordinary general meeting of shareholders for the company 中源协和细胞基因工程股份有限公司. It includes information about the meeting date, voting methods, agenda items (such as proposals to add new board members), voting procedures, registration details, and proxy authorization forms. The content focuses on informing shareholders about the meeting logistics and agenda rather than reporting on the results of the meeting or providing financial data. It is not a report of voting results, nor is it a full annual or interim report, audit report, or earnings release. The document is a formal notice or announcement about the meeting itself, which fits the category of AGM Information (AGM-R). The document length is 3110 characters, which is consistent with a detailed meeting notice rather than a full report. Therefore, the classification is AGM Information (AGM-R).
2018-11-27 Chinese
关于控股股东部分股权质押的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the pledge of shares by the controlling shareholder of the company. It details the number of shares pledged, the purpose of the pledge, and the risks involved. There is no financial report, earnings data, or management discussion. The document is a regulatory announcement about share pledge (a capital/financing related update). This fits best under Capital/Financing Update (CAP). The document length is short and it is not a report publication or certification, so it is not RPA or RNS. Therefore, the classification is CAP with high confidence.
2018-11-27 Chinese
关于转让浙江赛尚医药科技有限公司67%股权的进展公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by the company 中源协和细胞基因工程股份有限公司 regarding the progress of the transfer of 67% equity in 浙江赛尚医药科技有限公司. It details the background of the equity transfer agreement, the failure of the counterparty to pay the agreed amount, subsequent legal actions, and ongoing litigation. The document is an update on a specific transaction and legal proceeding rather than a full financial report, audit, or earnings release. It does not contain financial statements or detailed financial analysis. It is not a merger or acquisition announcement but rather a progress update on a capital transaction and related legal matters. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2018-11-26 Chinese
关于控股股东部分股权解除质押的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the release of a portion of pledged shares by the controlling shareholder and the cumulative pledge status of shares. It contains no financial statements, no detailed financial data, and no mention of a report or meeting. It is a regulatory announcement about share pledge status, which fits best under the category of Regulatory Filings (RNS) as it does not fit other more specific categories like Share Issue/Capital Change or Director's Dealing. The document length is short (566 characters), and it is a straightforward announcement without detailed financial or management information.
2018-11-23 Chinese
2018年第七次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as materials for the 2018 Seventh Extraordinary General Meeting of Shareholders of Zhongyuan Xiehe Cell Gene Engineering Co., Ltd. It contains detailed meeting agenda, voting procedures, and proposals for the election of new board directors. The content focuses on board member nominations and voting, with no financial statements or earnings data. The document length is 3445 characters, which is relatively short and consistent with meeting materials rather than a full report. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual or Extraordinary General Meeting. Therefore, the document is classified as AGM Information (AGM-R).
2018-11-22 Chinese
关于召开2018年第七次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about the convening of the 2018 seventh extraordinary general meeting of shareholders, including details about the meeting date, voting methods, agenda items (such as proposals to add new directors), and procedural instructions for shareholders. It does not contain financial statements or results but is an announcement related to a shareholders' meeting. The content focuses on meeting logistics and agenda rather than the meeting's voting results or the actual report of the meeting outcomes. Therefore, it fits best as AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings.
2018-11-16 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.